Get the app
public
ios_share
OncoPharm
chevron_right
Zenocutuzumab
Dec 5, 2024
12:45
forum
Ask episode
play_arrow
Play
view_agenda
Chapters
auto_awesome
Transcript
info_circle
Episode notes
A first-in-class approval of a bispecific HER2-HER3 monoclonal antibody for NRG1 fusion (+) NSCLC and pancreatic cancer.
